2024 Max Perutz Lecture: Antisense Modulation of RNA Splicing for Rare Disease Therapy - In Person Only

Add to your list(s) Download to your calendar using vCal

• Adrian R. Krainer, Ph.D., St. Giles Foundation Professor, Cold Spring Harbor Laboratory
• Monday 11 November 2024, 11:00-12:00
• In person in the Max Perutz Lecture Theatre (CB2 0QH) .

If you have a question about this talk, please contact Scientific Meetings Co-ordinator.

I will describe the design, development, and therapeutic applications of antisense oligonucleotides (ASOs) that alter the splicing patterns of, and/or degrade, target transcripts. I will focus on CNS indications, including the development and clinical impact of nusinersen (Spinraza)—the first approved drug for spinal muscular atrophy—as well as our ongoing preclinical development of ASOs for a lethal pediatric brain cancer, H3K27 -altered diffuse midline glioma.

This talk is part of the MRC LMB Seminar Series series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Biology
• CCC talks for website
• Cambridge Immunology
• Centre for Health Leadership and Enterprise
• In person in the Max Perutz Lecture Theatre (CB2 0QH)
• Liam
• Life Sciences
• Life Sciences
• ME Seminar
• MRC LMB Seminar Series
• Neurons, Fake News, DNA and your iPhone: The Mathematics of Information
• cri
• my_list
• other talks
• rc781

Note that ex-directory lists are not shown.